NCT05021978View on ClinicalTrials.gov

A Clinical Trial of PRAX-944 in Participants With Essential Tremor

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

March 24, 2022

Study Completion Date

March 24, 2022

Conditions
Essential Tremor
Interventions
DRUG

Part A: 20 and 40 mg PRAX-944

Once daily oral treatment

DRUG

Part B: 120 mg PRAX-944

Once daily oral treatment with titration

DRUG

Part B: 120 mg PRAX-944 and Placebo

Once daily oral treatment with titration followed by placebo

Trial Locations (9)

1023

Praxis Research Site, Grafton

2305

Praxis Research Site, New Lambton Heights

3004

Praxis Research Site, Melbourne

3050

Praxis Research Site, Parkville

3065

Praxis Research Site, Fitzroy

4215

Praxis Research Site, Southport

8011

Praxis Research Site, Christchurch

33980

Praxis Research Site, Port Charlotte

99202

Praxis Research Site, Spokane

Sponsors
All Listed Sponsors
lead

Praxis Precision Medicines

INDUSTRY